7 June 2022
ANANDA
DEVELOPMENTS PLC
(“Ananda” or the “Company”)
Reminder to
Warrant Holders
The Directors would like to remind those shareholders that
received all or a portion of their holding of ordinary shares of
0.2p each in the Company (“Ordinary Shares”) via the distribution
by URA Holdings plc which took place in May
2021 (the “Distribution”), that the warrants over Ordinary
Shares which they received as part of the Distribution (“Warrants”)
will expire at 17.00 on 11 June
2022.
As set out in the letter which accompanied the share
certificate and Warrant agreement at the time of the Distribution,
the Warrants are exercisable at 0.45p per share and the Ordinary
Shares arising on exercise will be subject to a 12 month lock-in
from the date of exercise.
Holders of Warrants who wish to exercise their Warrants should
follow the instructions in the Warrant agreement or contact
any agent holding the Warrants on their behalf. Any questions
regarding the exercise of the Warrants may be addressed to
ir@anandadevelopments.com or to
steven.johnstone@slcregistrars.com.
-Ends-
The Directors of the Company accept responsibility for the
contents of this announcement.
ANANDA DEVELOPMENTS
PLC
Chief Executive Officer
Melissa Sturgess
Investor Relations
Jeremy Sturgess-Smith |
+44 (0)7463 686
497
ir@anandadevelopments.com |
PETERHOUSE CAPITAL
LIMITED
Corporate Finance
Mark Anwyl
Corporate Broking
Lucy Williams
Duncan Vasey |
+44 (0)20 7469
0930 |
About Ananda Developments
Ananda is an AQSE-listed medical cannabis company creating
UK-based operations to grow and provide carbon zero, consistent,
medical cannabis for the UK and international markets.
The UK medical cannabis market is predicted to be worth £450m by
2025 and the European market is predicted to be worth USD4.2bn by 2027.
For more information, please visit:
https://anandadevelopments.com/